(Q34089085)

30 July 2017

1 reference

title

Overview of vaccinology with special reference to papillomavirus vaccines (English)

1 reference

30 July 2017

1 reference

1

Hilleman MR

1 reference

30 July 2017

publication date

1 October 2000

1 reference

Journal of Clinical Virology

30 July 2017

published in

1 reference

30 July 2017

volume

19

1 reference

30 July 2017

issue

1-2

1 reference

30 July 2017

page(s)

79-90

1 reference

CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Modulating the immune response to genetic immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Adjuvants--a classification and review of their modes of action

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

DNA vaccines for viral diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Protection against papillomavirus with a polynucleotide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

New developments in adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

The new herpesviruses: emerging pathogens of dermatological interest

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Innate immunity and the biological relevance of the acquired immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Viruses and cancers: possible role of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Immunology of papillomavirus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Papillomavirus oncoproteins as vaccine candidates

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Is vaccination against human papillomavirus a possibility?

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Shapes of MHC restriction

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Oral tolerance in disease

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

TESTS IN HAMSTERS FOR ONCOGENIC QUALITY OF ORDINARY VIRUSES INCLUDING ADENOVIRUS TYPE 7.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Marek's disease vaccine: its implications in biology and medicine

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Yeast recombinant hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Six decades of vaccine development--a personal history

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

A simplified vaccinologists' vaccinology and the pursuit of a vaccine against AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Personal historical chronicle of six decades of basic and applied research in virology, immunology, and vaccinology

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Prospects for a vaccine against human papillomavirus

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Phylogenetic perspectives in innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

MHC class I-restricted CTL responses to exogenous antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Cytokines: Principles and prospects

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

The role of the proteasome system and the proteasome activator PA28 complex in the cellular immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Selection of potent immunological adjuvants for vaccine construction

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Unique molecular surface features of in vivo tolerized T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

The toll of innate immunity on microbial pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Human papillomavirus vaccines for cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Microparticles and polymers for the mucosal delivery of vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

CpG-containing oligonucleotides are efficient adjuvants for induction of protective antiviral immune responses with T-cell peptide vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Cell-specific targeting with retroviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Dendritic cells: a link between innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Cytokines and costimulatory molecules as genetic adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Fully mobilizing host defense: building better vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

The therapeutic potential of plant-derived vaccines and antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Immunity, components of the immune system and immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

The Cell Cycle: A Review

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Papillomavirus-like particle vaccines for cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Replication of human papillomaviruses in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Multi-epitope DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

New concepts on the role of human papillomavirus in cell cycle regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Elegantly presented DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Genomes and proteomes: towards a multidimensional view of biology

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

The discovery of MHC restriction

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

Viruses in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900132-3

7 January 2021

10.1016/S1386-6532(00)00132-3

Identifiers

DOI

1 reference

30 July 2017

1 reference